A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)

Clinical trial NCT05673460 · COMPLETED

Trial details

NCT number: NCT05673460
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mature B-cell Neoplasms

Start date: 2023-02-13
Primary completion: 2025-04-28
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.